| Literature DB >> 15675908 |
Abstract
Tramadol is a synthetic analgesic new to the Australasian market where its use is rapidly increasing. It is used extensively overseas, particularly in Europe where it has been popular since its introduction in Germany in the late 1970s. Tramadol has a dual mechanism of action: weak mu opioid receptor agonist and a reuptake inhibitor of serotonin and noradrenaline. Thus, it has distinct advantages and disadvantages compared to other available analgesics. Its use is advocated in a variety of acute and chronic pain states as well as some non-analgesic applications. The use of tramadol in an emergency setting is not well studied, with most published trials assessing its efficacy and tolerability in postoperative or dental models. This literature review concludes that tramadol does not offer any particular benefits over existing analgesics for the majority of emergency pain relief situations.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15675908 DOI: 10.1111/j.1742-6723.2005.00671.x
Source DB: PubMed Journal: Emerg Med Australas ISSN: 1742-6723 Impact factor: 2.151